Drug and alcohol use among people living with HIV in care in the United States by geographic region.
Drug and alcohol use among people living with HIV in care in the United States by geographic region.
复制标题
DOI:
10.1080/09540121.2021.1874274
复制
发表时间:
2021-12
影响因子:
1.7
通讯作者:
Delaney, Joseph A. C.
中科院分区:
文献类型:
--
作者:
Crane, Heidi M.;Nance, Robin M.;Whitney, Bridget M.;Ruderman, Stephanie;Tsui, Judith I.;Chander, Geetanjali;McCaul, Mary E.;Lau, Bryan;Mayer, Kenneth H.;Batey, D. Scott;Safren, Steven A.;Moore, Richard D.;Eron, Joseph J.;Napravnik, Sonia;Mathews, W. Chris;Fredericksen, Rob J.;Hahn, Andrew W.;Mugavero, Michael J.;Lober, William B.;Saag, Michael S.;Kitahata, Mari M.;Delaney, Joseph A. C.
Substance use in the U.S. varies by geographic region. Opioid prescribing practices and marijuana, heroin, and methamphetamine availability are evolving differently across regions. We examined self-reported substance use among people living with HIV (PLWH) in care at seven sites from 2017-2019 to understand current regional substance use patterns. We calculated the percentage and standardized percentage of PLWH reporting current drug use and at-risk and binge alcohol use by U.S. Census Bureau geographic region and examined associations in adjusted logistic regression analyses. Among 7,686 PLWH, marijuana use was the most prevalent drug (30%), followed by methamphetamine/crystal (8%), cocaine/crack (7%), and illicit opioids (3%). One-third reported binge alcohol use (32%). Differences in percent of current use by region were seen for marijuana (24-41%) and methamphetamine/crystal (2-15%), with more use in the West and Northeast, and binge alcohol use (26-40%). In adjusted analyses, PLWH in the Midwest were significantly less likely to use methamphetamine/crystal (aOR: 0.13;0.06-0.25) or illicit opioids (aOR:0.16;0.05-0.53), and PLWH in the Northeast were more likely to use cocaine/crack (aOR:1.59;1.16-2.17), compared to PLWH in the West. Understanding differences in substance use patterns in the current era, as policies continue to evolve, will enable more targeted interventions in clinical settings among PLWH.
登录
查看更多内容
影响因子:
2.3
作者:
Hatfield LA;Horvath KJ;Jacoby SM;Simon Rosser BR
通讯作者:
Simon Rosser BR
影响因子:
1.5
作者:
Feinstein, Brian A.;Moody, Raymond L.;Mustanski, Brian
通讯作者:
Mustanski, Brian
影响因子:
3
作者:
Jensen RE;Rothrock NE;DeWitt EM;Spiegel B;Tucker CA;Crane HM;Forrest CB;Patrick DL;Fredericksen R;Shulman LM;Cella D;Crane PK
通讯作者:
Crane PK
影响因子:
11.8
作者:
Kozak, Michael S.;Mugavero, Michael J.;Willig, James H.
通讯作者:
Willig, James H.
影响因子:
4.4
作者:
Crane, Heidi M.;Crane, Paul K.;Fredericksen, Rob J.
通讯作者:
Fredericksen, Rob J.